EUKEDOS risk profile

42 Elevated one input has moved against it

Measured 21 October 2026 from EUK.MI's filed statements. Recomputed nightly.

42 (Elevated), driven by Leverage and coverage at 91, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation62StretchedStableDrawdown from the 52-week high — 28.4%
Operating pressure37NormalStableCosts outgrowing revenue — -0.5 percentage points
Cash conversion67StretchedEasingCapital spending against operating cash — 0.93x
Leverage and coverage91AcuteWorseningNet debt to EBITDA — 11.46x
Competitive position18ContainedStableRevenue-growth gap against peers — +6.8 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for EUKEDOS